EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Klinische Studie (Phase III)Open Access · CC BY 4.0

Safety and tolerability of short‐term infusions of intravenous lacosamide in pediatric patients with epilepsy: An open‐label, phase 2/3 trial

Mark Kristof Farkas iD, Cynthia Beller, Ali Bozorg, Carrie McClung, Robert Roebling, Tanisia Yates, Nancy Yuen, Iryna Makedonska

Epilepsia Open · 2023

DOI: 10.1002/epi4.12682 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift Epilepsia Open, 2023. Verfasst von Mark Kristof Farkas und 7 weiteren Autor:innen. Beteiligte Einrichtung: First Department of Pediatrics, Semmelweis University, Budapest, Hungary. Hauptthemen laut MEDLINE: Anticonvulsants, Epilepsy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UCB Pharma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective The objective of this study is to evaluate the safety and tolerability of intravenous (IV) lacosamide infusion in patients aged ≥1 month to

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticonvulsantsEpilepsyChildHumansAcetamidesLacosamideSeizures

Stichwörter der Autor:innen

antiseizure medicationfocal seizureintravenous lacosamidepediatricprimary generalized tonic-clonic seizures

Substanzen

AcetamidesAnticonvulsantsLacosamide

Autor:innen und Institutionen

  • First Department of Pediatrics, Semmelweis University, Budapest, Hungary.
  • UCB Pharma, Morrisville, North Carolina, USA.
  • UCB Pharma, Monheim am Rhein, Germany.
  • Dnipro City Pediatric Clinical Hospital, Dnipro, Ukraine.

ORCID-Profile: Mark Kristof Farkas

Förderung

  • UCB Pharma

Zitieren

APA

Farkas, M. K., Beller, C., Bozorg, A., McClung, C., Roebling, R., Yates, T., Yuen, N., & Makedonska, I. (2023). Safety and tolerability of short‐term infusions of intravenous lacosamide in pediatric patients with epilepsy: An open‐label, phase 2/3 trial. Epilepsia Open. https://doi.org/10.1002/epi4.12682

Vancouver

Farkas MK, Beller C, Bozorg A, McClung C, Roebling R, Yates T, et al. Safety and tolerability of short‐term infusions of intravenous lacosamide in pediatric patients with epilepsy: An open‐label, phase 2/3 trial. Epilepsia Open. 2023. doi:10.1002/epi4.12682

BibTeX
@article{Farkas2023,
  author = {Farkas, Mark Kristof and Beller, Cynthia and Bozorg, Ali and McClung, Carrie and Roebling, Robert and Yates, Tanisia and Yuen, Nancy and Makedonska, Iryna},
  title = {Safety and tolerability of short‐term infusions of intravenous lacosamide in pediatric patients with epilepsy: An open‐label, phase 2/3 trial},
  journal = {Epilepsia Open},
  year = {2023},
  doi = {10.1002/epi4.12682}
}
Kostenlos starten →